AgriMetis announces publication of additional SpinoMetis™ patent applications

AgriMetis™, LLC recently announced that a fifth international patent application covering its insecticide portfolio of novel SpinoMetis™ spinosyn analogs has published.

In March 2018, Monsanto Company (now a part of Bayer AG) and AgriMetis announced an exclusive collaboration for Monsanto’s continued research with AgriMetis’ SpinoMetis platform, and the compounds exemplified in this application are included in that collaboration.

“The novel compounds described in AgriMetis’ numerous SpinoMetis-related applications show strong performance, and we look forward to working with the Bayer and Monsanto team to advance them through the development process,” said Brian Green, AgriMetis’ VP of Research and Development.

With this addition to its growing patent portfolio, AgriMetis continues to progress toward delivering commercially viable products to the agricultural crop protection industry through an extensive and expanding research and development pipeline. For more information on this PCT publication, a link is provided below:https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018132288